Genomma Lab Internacional
Genomma Lab Internacional, a leading player in the pharmaceutical and personal care industry, is headquartered in Mexico (MX) and operates extensively across Latin America and the United States. Founded in 2000, the company has achieved significant milestones, including rapid expansion and a diverse product portfolio that encompasses over-the-counter medications, skincare, and dietary supplements. Renowned for its innovative approach, Genomma Lab offers unique formulations that cater to various health and wellness needs, setting it apart in a competitive market. With a strong commitment to quality and research, the company has established a solid market position, recognised for its effective solutions and consumer trust. Genomma Lab Internacional continues to thrive, driven by its dedication to enhancing the well-being of its customers.
DitchCarbon Score
How does Genomma Lab Internacional's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Other Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Genomma Lab Internacional's score of 32 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Genomma Lab Internacional's reported carbon emissions
In 2023, Genomma Lab Internacional reported total carbon emissions of approximately 44,075,120 kg CO2e, with Scope 1 emissions at about 3,100,840 kg CO2e and Scope 2 emissions at around 4,740,490 kg CO2e. The company has disclosed emissions across all three scopes, indicating a comprehensive approach to tracking its carbon footprint. Over the years, Genomma Lab has shown fluctuations in its emissions. For instance, in 2022, total emissions were approximately 43,466,980 kg CO2e, with Scope 1 and Scope 2 emissions at about 2,737,470 kg CO2e and 4,041,110 kg CO2e, respectively. In 2021, the total emissions peaked at approximately 57,262,760 kg CO2e, highlighting a significant increase in emissions primarily driven by Scope 3 activities. Despite these figures, Genomma Lab has not publicly committed to specific reduction targets or initiatives, as indicated by the absence of documented reduction targets or climate pledges. This lack of formal commitments may reflect a broader industry trend where companies are increasingly scrutinised for their environmental impact and sustainability practices. Overall, while Genomma Lab Internacional has made strides in tracking its emissions, the absence of clear reduction targets suggests an opportunity for the company to enhance its climate commitments and align with industry standards for sustainability.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 198,500 | 000,000 | 00,000 | 0,000,000 | 0,000,000 | 0,000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 570,700 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | 0,000,000 | 000,000 | 000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Genomma Lab Internacional is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
